To the Editor.
—Chronic inflammatory demyelinating polyneuropathy is a disease of the peripheral neuron with unknown cause. Management of the disorder is still a subject of study. Recently, several studies1-5 have demonstrated that treatment with high-dose intravenous immunoglobulin has a clear effect on chronic inflammatory demyelinating polyneuropathy. Repeated treatments for a long period are common.5 In some cases, it might be better to use plasma exchange.6 We present a patient with chronic inflammatory demyelinating polyneuropathy who was treated with high-dose intravenous immunoglobulin several times, resulting in short-term amelioration with rapid new deterioration with an initially unknown cause; plasma exchange caused rapid improvement without new deterioration.
Report of a Case.
—A 66-year-old man was admitted with paresthesia of the lower limbs that had appeared rather suddenly. Later on, progressive weakness of the legs developed, which gradually extended to the arms over a period of several weeks. There were
Prick MJJ, Verhagen WIM. Chronic Inflammatory Demyelinating Polyneuropathy: Immunoglobulins or Plasmapheresis? Arch Neurol. 1991;48(11):1118–1119. doi:10.1001/archneur.1991.00530230026013
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: